Home Prostate / Prostate Cancer Exact Sciences Positions Itself as Cancer Testing Provider of Future as COVID...

Exact Sciences Positions Itself as Cancer Testing Provider of Future as COVID Crisis Continues

21
0

NEW YORK – As the COVID-19 crisis shows no signs of abating, some US-based diagnostics companies are reporting second quarter earnings that show the pandemic’s negative impact on their core businesses being offset to varying degrees by revenues from COVID diagnostics.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

https://www.genomeweb.com/business-news/exact-sciences-positions-itself-cancer-testing-provider-future-covid-crisis-continues

This site uses Akismet to reduce spam. Learn how your comment data is processed.